Board of Directors

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Learn More

Geoffrey M. Parker

Geoffrey M. Parker has been a director of Perrigo since November 2016. Since October 2023, Mr. Parker has served as Chief Financial Officer of Allogene Therapeutics, Inc, a clinical-stage biotechnology company. Mr. Parker previously served as Chief Financial Officer of Tricida, Inc., a biopharmaceutical company. Before that Mr. Parker served as Chief Financial Officer of Anacor Pharmaceuticals, a biopharmaceutical company, from September 2010 to May 2015. From 1997 to 2009, Mr. Parker led the West Coast Healthcare Investment Banking practice at Goldman Sachs, where he advised leading companies in the biotechnology, life science tools and medical device industries. Mr. Parker served as a member of the board of directors of ChemoCentryx from December 2009 to 2022, Genomic Health from June 2016 until November 2019 and Sunesis Pharmaceuticals from March 2016 until December 2017.